ArticleDystonia (Lausanne, Switzerland)2026
Effect of transcranial magnetic stimulation on focal hand dystonia: a systematic review and meta-analysis.
Article in Dystonia (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Focal hand dystonia (FHD) is a rare and disabling movement disorder with limited treatment options. Transcranial magnetic stimulation (TMS) has shown promise as a non-invasive neuromodulation therapy for dystonia, but its efficacy in FHD remains unclear due to heterogeneity across prior studies and mixed results from broader noninvasive brain stimulation meta-analyses. Objective: To systematically review and synthesize the effects of TMS on behavioral symptoms in individuals with FHD. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, and Web of Science were searched through January 2026 for studies applying TMS in individuals with FHD. Studies reporting behavioral outcome measures of dystonia severity were included. Random-effects meta-analyses were performed to estimate pooled effect sizes using Hedges' g for (1) pre-versus post-TMS comparisons and (2) active-TMS versus sham-TMS comparisons. Study quality and risk of bias were assessed using Cochrane Risk of Bias and PEDro scales. Publication bias was assessed using funnel plot and Egger's test. Results: Nine studies met inclusion criteria, comprising a total of 111 individuals with FHD. Meta-analysis demonstrated a moderate and statistically significant improvement in dystonia symptoms following TMS compared with pre-TMS (Hedges' g = 0.36, 95% CI [0.17, 0.56], p < 0.001). In studies including sham controls (n = 8; 102 participants), active-TMS was associated with significantly greater symptom improvement compared with sham stimulation (Hedges' g = 0.35, 95% CI [0.12, 0.57], p = 0.002). Between study heterogeneity was low for both analyses, and no evidence of significant publication bias was detected. Conclusion: TMS is associated with a mild to moderate improvement in behavioral symptoms of FHD. These findings support further investigation of TMS as a non-invasive therapeutic option for FHD and highlight the need for larger, well-designed clinical trials to optimize stimulation parameters and assess durability of treatment effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.